Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease

American Journal of Respiratory and Critical Care Medicine(2022)10.1164/rccm.202111-2606ocSource: DataRank Database

Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease is a research paper published in American Journal of Respiratory and Critical Care Medicine (2022). On theSindex it has a DataRank of 1.9. It has been cited 75 times, with 68 citing works in its 1-hop citation network.

N/A

1.9DataRank · unranked

Scored on demand from live citation data

Open Access75 citations · 68 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)OA: hybridTopics (26)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 35%Citation Network 65%

Base Score Contribution

0.650

From this paper's citation signal

Citation Network Contribution

1.2

From 45 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 68 citers.

Airway Mucus Dysfunction in COVID-19
American Journal of Respiratory and Critical Care Medicine20227 citations21 referencesContributes 0.099
Lung T2* mapping using 3D ultrashort TE with tight intervals δTE
Magnetic Resonance in Medicine20234 citations19 referencesContributes 0.085
Lung Remodeling Regions in Long-Term Coronavirus Disease 2019 Feature Basal Epithelial Cell Reprogramming
American Journal Of Pathology202324 citations42 referencesContributes 0.077
Pharmacological Activities of Warm Alkaline Hydrogen Peroxide Solution and Therapeutic Potential in Medicine: Physical-Chemical Reprofiling as a Promising Lead for Drug Discovery
Anti-Infective Agents20245 citations24 referencesContributes 0.075
Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study
Frontiers in Microbiology20225 citations28 referencesContributes 0.064

Authors (25)

Takanori Asakura ORCID,Caitlin E. Edwards ORCID,Hong Dang ORCID,Yu Mikami ORCID,Kenichi Okuda ORCID

Live enrichment

PubMed:35816430 PMC:PMC9746856

NIH

Grant: UH3 HL123645

NIH

Grant: R01 HL136961

NIH

Grant: P30 DK 065988

NIH

Grant: P30 DK 034987

NIH

Grant: P01 HL108808

NIH

Grant: R01 HL155951

NIH

Grant: AI108197

NIH

Grant: AI157253

Cystic Fibrosis Foundation

Grant: BOUCHE19R0

Cystic Fibrosis Foundation

Grant: BOUCHE19XX0

Cystic Fibrosis Foundation

Grant: KATO20I0

Cystic Fibrosis Foundation

Grant: MIKAMI19XX0

Cystic Fibrosis Foundation

Grant: OKUDA20G0

Japan Society for the Promotion of Science

Grant: 2250

National Cancer Institute

Grant: 5P30CA016080-42

NIAID NIH HHS

Grant: R01 AI157253

NHLBI NIH HHS

Grant: U01 HL156655

NIAID NIH HHS

Grant: R01 AI108197

National Institutes of Health

Grant: 5UH3HL123645-05

Synthesis of Effective and Safe Mucolytics for Pulmonary Disease

National Institutes of Health

Grant: 5R01HL136961-03

Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport

National Institutes of Health

Grant: 5P01HL108808-08

Development of Novel Mycolytic Therapies for Lung Disease

National Institutes of Health

Grant: 3P30DK065988-10S1

Correction Core

National Institutes of Health

Grant: 5R01HL155951-05

Role of the ER stress transcription factor XBP1S in the development of idiopathic pulmonary fibrosis

University of North Carolina at Chapel Hill

hybridLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1164/rccm.202111-2606oc

publisherhttps://academic.oup.com/ajrccm/article-pdf/206/11/1336/67000696/ajrccm_206_11_1336.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9746856

Europe_PMChttps://europepmc.org/articles/PMC9746856

Europe_PMChttps://europepmc.org/articles/PMC9746856?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

LungMucusHumansRNAPrevalenceMucin-5BMucin 5ACErbB ReceptorsCOVID-19SARS-CoV-2

Keywords

MUC5ACMuc5bAirway MucinCovid-19Sars-cov-2ErbB ReceptorsMucusPrevalenceHumansRNAOriginal ArticlesMucin 5ACMucin-5BLung

Related Papers (10)

Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Top 1%

10.4DataRank

The Lancet(2020)

co-cited

10.1016/s0140-6736(20)30752-2

Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis

N/A

18.4DataRank · unranked

Science Advances(2020)

co-cited

10.1126/sciadv.abd4049

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

N/A

7.4DataRank · unranked

Emerging Microbes & Infections(2020)

co-cited

10.1080/22221751.2020.1858177

Cross-Talk Between Alveolar Macrophages and Lung Epithelial Cells is Essential to Maintain Lung Homeostasis

Frontiers in Immunology(2020)

co-cited

10.3389/fimmu.2020.583042

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract

N/A

6.1DataRank · unranked

EBioMedicine(2020)

co-cited

10.1016/j.ebiom.2020.102976

Mechanisms of SARS-CoV-2 entry into cells

N/A

8.7DataRank · unranked

Nature Reviews Molecular Cell Biology(2021)

co-cited

10.1038/s41580-021-00418-x

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

N/A

10.7DataRank · unranked

Nature(2021)

co-cited

10.1038/s41586-021-03570-8

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19

Science Translational Medicine(2021)

co-cited

10.1126/scitranslmed.abj7790

SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters

N/A

5.3DataRank · unranked

Nature Communications(2021)

co-cited

10.1038/s41467-021-25156-8

Air pollution and the pandemic: Long‐term PM2.5 exposure and disease severity in COVID‐19 patients

Respirology(2021)

co-cited

10.1111/resp.14140

Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (25)

Funding (24 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (10)